PMC:7096777 / 1313-1649 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":180,"end":188},"obj":"Species"},{"id":"41","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"42","span":{"begin":167,"end":176},"obj":"Disease"},{"id":"43","span":{"begin":209,"end":217},"obj":"Disease"},{"id":"44","span":{"begin":299,"end":307},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Tax:9606"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:C000657245"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D003643"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C000657245"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. The mortality of patients hospitalised due to COVID-19 is ca 4% [1]. In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/Europ"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T32","span":{"begin":209,"end":217},"obj":"SP_7"},{"id":"T31","span":{"begin":299,"end":307},"obj":"SP_7"},{"id":"T33","span":{"begin":9,"end":17},"obj":"SP_7"}],"text":"% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. The mortality of patients hospitalised due to COVID-19 is ca 4% [1]. In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/Europ"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"T17","span":{"begin":209,"end":217},"obj":"Disease"},{"id":"T18","span":{"begin":299,"end":307},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. The mortality of patients hospitalised due to COVID-19 is ca 4% [1]. In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/Europ"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":32,"end":33},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T9","span":{"begin":224,"end":229},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. The mortality of patients hospitalised due to COVID-19 is ca 4% [1]. In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/Europ"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":163,"end":231},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. The mortality of patients hospitalised due to COVID-19 is ca 4% [1]. In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/Europ"}